PROMISE, OASIS, and SWAT: Evaluating the Future of Sepsis Care

Affiliations

Comment

Brijesh Patel et al. Am J Respir Crit Care Med. 2016.

. 2016 Oct 1;194(7):907-908.

doi: 10.1164/rccm.201604-0704RR.

¹ Section of Pulmonary, Critical Care, Environmental, and Sleep Medicine, Virginia Tech Carilion School of Medicine, Carilion Clinic, Roanoke, Virginia.

No abstract available

Comment on

Trial of early, goal-directed resuscitation for septic shock.
Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, Rowan KM; ProMISe Trial Investigators. Mouncey PR, et al. N Engl J Med. 2015 Apr 2;372(14):1301-11. doi: 10.1056/NEJMoa1500896. Epub 2015 Mar 17. N Engl J Med. 2015. PMID: 25776532 Clinical Trial.
Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial.
Vincent JL, Marshall JC, Dellinger RP, Simonson SG, Guntupalli K, Levy MM, Singer M, Malik R; Oral tAlactoferrin in Severe sepsIS Study Investigators. Vincent JL, et al. Crit Care Med. 2015 Sep;43(9):1832-8. doi: 10.1097/CCM.0000000000001090. Crit Care Med. 2015. PMID: 26010687 Clinical Trial.
Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED.
Hayden GE, Tuuri RE, Scott R, Losek JD, Blackshaw AM, Schoenling AJ, Nietert PJ, Hall GA. Hayden GE, et al. Am J Emerg Med. 2016 Jan;34(1):1-9. doi: 10.1016/j.ajem.2015.08.039. Epub 2015 Aug 28. Am J Emerg Med. 2016. PMID: 26386734 Free PMC article.